Clinical performance of self‐assembling peptide P11‐4 in the treatment of initial proximal carious lesions: A practice‐based case series
M Schlee, T Schad, JH Koch… - Journal of investigative …, 2018 - Wiley Online Library
Aim The aim of the present study was to investigate the clinical performance of self‐
assembling peptide P11‐4 on non‐cavitated initial proximal carious lesions 12 months after
treatment. Methods Twenty‐six patients, aged between 18 and 65 years, with 35 carious …
assembling peptide P11‐4 on non‐cavitated initial proximal carious lesions 12 months after
treatment. Methods Twenty‐six patients, aged between 18 and 65 years, with 35 carious …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论